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Abstract
Ectromelia virus is the causative agent of mousepox, an acute exanthematous disease of mouse colonies in Europe, Japan, China, and
the U.S. The Moscow, Hampstead, and NIH79 strains are the most thoroughly studied with the Moscow strain being the most infectious
and virulent for the mouse. In the late 1940s mousepox was proposed as a model for the study of the pathogenesis of smallpox and
generalized vaccinia in humans. Studies in the last five decades from a succession of investigators have resulted in a detailed description
of the virologic and pathologic disease course in genetically susceptible and resistant inbred and out-bred mice. We report the DNA sequence
of the left-hand end, the predicted right-hand terminal repeat, and central regions of the genome of the Moscow strain of ectromelia virus
(approximately 177,500 bp), which together with the previously sequenced right-hand end, yields a genome of 209,771 bp. We identified
175 potential genes specifying proteins of between 53 and 1924 amino acids, and 29 regions containing sequences related to genes predicted
in other poxviruses, but unlikely to encode for functional proteins in ectromelia virus. The translated protein sequences were compared with
the protein database for structure/function relationships, and these analyses were used to investigate poxvirus evolution and to attempt to
explain at the cellular and molecular level the well-characterized features of the ectromelia virus natural life cycle.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
The poxvirus family is divided into two subfamilies:
Entomopoxvirinae (poxviruses of insects) and Chordopox-
virinae (poxviruses of the vertebrates). Poxviruses replicate
in the cytoplasm of cells and assemble large virions that are
visible in the light microscope. The structurally complex
virions contain a double-stranded DNA genome of between
140 and 280 kb, and an early gene transcription system
(Moss, 2001). Poxviruses are classified into genera by com-
paring cross-protection in animal studies, cross-neutraliza-
tion of infectivity in tissue culture, and genomic DNA
sequence information.
Genomic sequences have been determined for represen-
tative species from seven of the eight vertebrate poxvirus
genera: avipoxvirus (fowlpox virus) (Afonso et al., 2000);
capripoxvirus (lumpy skin disease virus, sheeppox virus,
and goatpox virus) (Tulman et al., 2001, 2002); leporipox-
virus [shope fibroma virus (Willer et al., 1999) and myxoma
virus (Cameron et al., 1999)]; molluscipoxvirus (molluscum
contagiosum virus) (Senkevich et al., 1997); orthopoxvirus
[monkeypox virus (Shchelkunov et al., 2002), camelpox
virus (Afonso et al., 2001; Gubser and Smith, 2002), vac-
cinia virus (Goebel et al., 1990), and variola virus (Massung
et al., 1994; Shchelkunov et al., 1995, 2000)]; suipoxvirus
(swinepox virus) (Afonso et al., 2002); and yatapoxvirus
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(Yaba-like disease virus) (Lee et al., 2001). The availability
of these genomic sequences has permitted the comparison
of distantly related orthologs to determine conserved amino
acids (aa), which in turn can facilitate bioinformatics pre-
dictions as to ORF function.
Ectromelia virus (ECTV) is the causative agent of
mousepox, an acute exanthematous disease of mouse colo-
nies in Europe, Japan, China, and the U.S. (Buller and
Palumbo, 1991; Fenner, 1982). The disease is on the decline
in vivariums due to improvements in animal husbandry and
health surveillance. The natural reservoir for ECTV is un-
known but one report provides evidence that wild mice may
be involved. Laboratory studies have shown ECTV to have
a very narrow host range, infecting only certain mouse
species (Buller et al., 1986; Fenner, 1982). A number of dif-
ferent strains of ECTV have been isolated which have been
shown to differ in their virulence for the mouse. The Moscow,
Hampstead, and NIH79 strains are the most thoroughly studied
with the Moscow strain being the most infectious and virulent
for the mouse. In the late 1940s mousepox was proposed as a
model for the study of the pathogenesis of smallpox and
generalized vaccinia in humans (Fenner, 1948). Studies in the
last five decades from a succession of investigators have re-
sulted in a detailed description of the virologic and pathologic
disease course in genetically susceptible (A, BALB/c, DBA/2,
and C3H/He) and resistant (C57BL/6 and AKR) inbred and
outbred mice; identification and characterization of the impor-
tant cell-mediated and innate responses for recovery from
infection; and the discovery of rmp-1, rmp-2, rmp-3, and
rmp-4 loci, which govern resistance to severe mousepox
(Brownstein and Gras, 1995; Brownstein, 1998; Delano and
Brownstein, 1995). Since varying mouse genotype, virus
strain, and dose of virus can manipulate disease patterns for a
given route of infection, ECTV infections of mice are one of
the best models for studying viral pathogenesis, and testing
efficacy of orthopoxvirus antivirals and vaccines.
In this study we report the DNA sequence of the left-
hand end, the predicted right-hand terminal repeat, and
central regions of the genome of the Moscow strain of
ECTV (approximately 177.5 kb), which together with the
previously sequenced right-hand end provide the entire pro-
tein coding region of the genome (Chen et al., 2000). The
translated protein sequences were compared with the pro-
tein database for structure/function relationships, and these
analyses have been used to investigate poxvirus evolution
and to explain at the cellular and molecular level the well-
characterized features of the ECTV natural life cycle.
Results and discussion
Overview of the structure of the genome of ectromelia
virus strain Moscow
We report 175,950 base pairs (bp) of contiguous se-
quence, which was assembled from 1832 independent se-
quencing reactions based on 16 overlapping PCR fragments
generated from genomic DNA of ECTV strain Moscow
(ECTV-MOS), and the predicted 1503-bp right-hand termi-
nal repeat. Each position was sequenced on both strands at
least once with an average coverage of 3.7-fold. This se-
quence, in addition to 32,318 bases sequenced previously,
constitutes a genome of 209,771 bp (Chen et al., 2000). The
presented sequence does not contain the hairpin termini of
the ECTV-MOS genome, but based on DNA homology
with closely related orthopoxvirus vaccinia [VACV, strain
Copenhagen (COP)], the ECTV-MOS sequence presented
here starts 136 bases from the terminus. This value is
consistent with the estimated position of the 5 primer
sequence containing a part of the concatamer resolution
motif, ATTTAGTGTCTAGAAAAAAA, which was used
to amplify the left terminal fragment, and restriction endo-
nuclease analysis of the terminal region of the genome
(Baroudy et al., 1982; Esposito and Knight, 1985; Goebel et
al., 1990; Merchlinsky, 1990; Stuart et al., 1991). As is
typical of the orthopoxviruses, the genome of ECTV-MOS
is AT-rich (67%), although there is considerable variation
between individual ORFs. Previous DNA restriction en-
zyme mapping analyses have shown genomes of orthopox-
viruses to have a central, highly conserved region. The
region between ORF 029 (VACV-COP F6L) and ORF 127
(VACV-COP A24R), which covers 99,798 nucleotides,
shows strong conservation of gene order, and approximately
97, 96, and 97% aa identity when compared to a similar
region of VACV-COP, variola virus strain Bangladesh
(VARV-BSH), and cowpox virus strain Brighton Red
(CPXV-BR) counterparts.
The inverted terminal repeat (ITR) reported here con-
tains 9413 bp. The right ITR junction falls within ORF 169
and thus a C-terminal fragment of this ORF, designated as
the noncoding Region D, is present in the left ITR (Fig. 1).
There are several specific structures contained in the or-
thopoxvirus ITR: terminal hairpin, the concatamer resolu-
tion motif, two conserved nonrepeating sequences, NR I and
NR II, and direct repeats on each side of the NR II region.
An alignment of the ITRs from VACV-COP, VARV-BSH,
cowpox virus strain Grishak (CPXV-GRI), and ECTV-
MOS shows that NR I and NR II regions are highly con-
served within these genomes (data not shown). The DR I of
ECTV-MOS, named for convention, is not in fact repeated
but contains one copy of a 68-bp element, which is similar
to the 70-bp element from the ITR of VACV-COP, and one
copy of a 25-bp element which is a portion of the 54-bp
element in VACV-COP. The second set of direct repeats is
represented by an 85-bp monomer, which is repeated 10.4
times. The 85-bp element can be aligned with the 54-bp
element from VACV-COP, by introducing a 31 nucleotide
insertion between positions 27 and 28 of the VACV-COP
element (data not shown). This 85-bp monomer is polymor-
phic at position 30 of the unit, where either an A or a G can
be present. Three genes (ORFs 001, 002, and 003) are
encoded within the left-hand ITR of the genome and there-
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fore are duplicated in the right-hand ITR (ORFs 170, 171,
and 172; Fig. 2).
The ECTV-MOS genome has two unique features when
compared to other orthopoxviruses. A small intergenic re-
gion in the ECTV-MOS genome, between nucleotides
16,879 (ORF 010) and 17,146 (ORF 010.5), contains sev-
eral different short AT-rich direct repeats with copy num-
bers of 2–14. Very similar, but not identical repeats are also
present in the Naval strain of ECTV (ECTV-NAV), indi-
cating that the repeats probably arose early after speciation
Fig. 1. Schematic representation of the left ITR of ECTV-MOS. The presumed hairpin loop (HL), concatemer resolution sequence (CR; hatched box), and
the nonrepeating regions NR I and NR II, which are highly conserved among VACV, VARV, and CPXV are indicated. Nucleotide numbers for this sequence
are shown at the bottom of the diagram. On each side of NR II are the direct repeat regions, DR I and DR II. The length of the repeat elements is indicated
under the thick bars. The relative positions of the first leftmost ORF (001) and the ORF-disrupted region D are shown. The left ITR ends at position 9413.
Fig. 2. ORF map of the ECTV-MOS genome. ORF map of ECTV strain Moscow genome. Scale in kb. Named ORF; direction shown by arrow;
Fragmented ORFs; readingframe shifts required to complete genes are shown; *indicates not all frameshifts shown; X indicates STOP codon;
Significant deletion at 5 end of ORF; ORF wraps around; Inverted terminal repeat.
167N. Chen et al. / Virology 317 (2003) 165–186
and that they represent a dynamic region of the genome
(http://www.sanger.ac.uk/Projects/Ectromelia-virus/). Dele-
tions between short direct repeats appear to be a common
feature in poxvirus genomes (Upton et al., 1994a), but
nothing is known about the mechanism by which the dele-
tions occur or how some repeated regions appear to be
maintained. After position 157,776 between ORFs 139 and
140, sequence analysis of PCR amplicons identified a C
tract that was heterogeneous in nature. Individual DNA
molecules from these PCR-amplicons were cloned and
DNA sequence analysis revealed five clones with 18 Cs,
two clones with 19 Cs, and one clone each with 16 Cs, 17
Cs, and 20 Cs. To confirm the heterogeneity of this region
in the genomic DNA, two independent ECTV-MOS
genomic DNA clones were sequenced. Clones E23 and B27
were found to have 19 and 21Cs, respectively. In the sub-
mitted GenBank file, the sequence was reported with 21 Cs
starting at nucleotide 157,777. The ECTV-NAV and ECTV-
WIE (accession No. AF 043238) strains have 11 and 8 Cs in
this position, respectively, confirming another highly poly-
morphic site in the ECTV genome. VACV (strains COP,
TIA, ANK, and WR) and VARV (strains IND, GAR, and
BSH) have three Cs in this position, whereas CPXV-BR has
four Cs one of which may represent a T3 C mutation. The
C tract is present in the NK cell receptor homologue
(VACV-A40R) in the genomes of VACV strains, but within
the intergenic region in the genomes of strains of VARV
because the orthologs are truncated.
ORFs predicted to encode proteins of at least 60 aa have
been assigned gene numbers starting from the left end of the
genome as aligned to VACV-COP. To increase the accuracy
of the annotation process, we have examined predicted
ORFs for experimental evidence of expression in other
orthopoxviruses, the presence of proximal transcription ini-
tiation and termination signals, and aa content and pI of the
predicted proteins (Upton, 2000). We have not annotated
small ORFs that significantly overlap with ORFs that are
well conserved in other poxviruses. We have separately
annotated regions of the ECTV-MOS genome that contain
gene fragments (alphabetically), rather than ascribing them
gene numbers (Fig. 2 and Table 1). An assignment as a gene
fragment was based on comparisons to poxvirus ORFs in
the database. To show the likelihood of a region producing
a fragment of the normal encoded protein, the nature of the
fragmentation is illustrated in Fig. 2. Using this approach
we identified 175 potential genes specifying proteins of
between 53 and 1924 aa, and 29 regions containing se-
quences related to genes predicted in other poxviruses but
unlikely to encode for functional proteins in ECTV-MOS.
Although our primary cutoff for predicted ORFs was 60 aa,
we have included two small ORFs, 014 and 117.5, due to
the existence of orthologs in a number of other poxvirus
Table 1
Regions (from Fig. 2) of ECTV-MOS genome containing fragments of genes present in other orthopoxviruses
Region Start Stop Orthologous ORF aa Putative function/motifs
A 4823 4621 CPXV-BR 008 672 Ankyrin repeats
B 5428 4975 CPXV-GRI K3R 167 CrmE; TNFR homolog
C 8157 6475 CPXV-BR 220 579 Ankyrin repeats
D 9413 8435 ECTV-MOS 169 1924 Membrane protein; disrupted by ITR junction
E 17395 17168 CPXV-BR 017 435 Ankyrin repeats
F 22467 20974 CPXV-BR 025 668 CPXV CHO host range
G 23735 22958 VACV-COP C9L 634 Ankyrin repeats
H 24183 23743 VACV-COP C8L 184 Unknown
I 26139 25535 VACV-COP C5L 204 Unknown
J 26745 26207 VARV-BSH D14L 316 Unknown
K 29859 29224 CPXV-BR 036 231 Unknown
L 32952 32290 VACV-COP M2L 220 Unknown
M 35581 35357 VACV-COP K3L 88 eIF-2 homologue
N 36910 35632 VACV-COP K4L 424 Phospholipase D-like
O 37903 38348 VACV-COP K7R 149 Unknown
P 43752 42709 VARV-BSH C9L 348 Unknown
Q 148391 146880 VARV-BSH A30L 498 P4c, inclusion factor
R 154219 154984 VACV-COP A37R 263 Unknown
S 157331 157879 VACV-COP A40R 168 Lectin (NK cell receptor)
T 163913 164403 VACV-COP A49R 162 Unknown
U 167228 167773 VACV-COP A52R 190 inhibits NK-B activation
V 168098 168657 CPXV-BR 191 186 CrmC; TNFR homologue
W 171533 172125 CPXV-BR 195 197 Guanylate kinase
X 179961 180812 CPXV-BR 204 501 Unknown
Y 189026 191413 CPXV-BR 213 800 Ankyrin repeats
Z 194724 195303 CPXV-BR 218 193 Similarity to VACV-COP C13L and C14L
CA 201615 203297 CPXV-BR 220 579 Ankyrin repeats
BA 204344 204797 CPXV-GRI K3R 167 CrmE; TNFR homologue
AA 204949 205151 CPXV-BR 008 672 Ankyrin repeats
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genomes. As in many other poxviruses, there is a strong
preference for ORFs within about 50 kb of the genomic
termini (40 ORFs) to be transcribed toward the closest
end of the genome. Fig. 2 indicates that the ORFs are
closely packed within the ECTV-MOS genome.
Essential genes for DNA replication, transcription, and
virion assembly
ECTV-MOS contains a complement of genes that are
orthologs of most of the orthopoxvirus genes involved in
virus replication, nucleotide metabolism, virion structure,
and assembly (Table 2). Examination of this group of es-
sential genes found ORF 137.5 to contain three separate
deletions that resulted in three translational frameshifts of
the predicted protein such that its length was 160 aa instead
of the 221 predicted for the VACV-COP A36R. The first
deletion of 5 bp after nucleotide 390 of the gene shifted the
reading frame, and after 12 more bp a second deletion of 4
bp restored the original reading frame that continued for 61
bp before a third 1 bp deletion. This final deletion resulted
in six more out-of-frame aa and a STOP codon. An identical
pattern of deletions in the A36R homologue was also ob-
served in ECTV-MP1 (Accession No. AJ315003). The
A36R homologue is an integral intracellular enveloped vi-
rus (IEV) membrane protein important for the microtubule-
mediated intracellular movement of IEV, and actin tail
formation, which is required for release of extracellular
enveloped virions (EEV). Also an A36R homologue was
important for maximum virulence of VACV-WR in a mu-
rine intranasal model (Parkinson and Smith, 1994). Previous
studies showed that residues 1–100 of A36R were sufficient
to mediate microtubule-based motility of VACV IEVs to
the cell periphery, and residues 1–117 were sufficient for
actin tail formation, but at reduced levels (Frischknecht et
al., 1999; Rietdorf et al., 2001). It is likely that the ECTV-
MOS homologue of A36R is at least partially functional as
ECTV-MOS produces comet-shaped plaques under liquid
overlay (M. Buller, unpublished data), and ECTV-MOS
causes the disease mousepox in inbred and outbred strains
of mice following infection by multiple routes.
A-type inclusion body protein
A-type inclusions (ATIs) are acidophilic cytoplasmic
masses also known as Marchal and Downie bodies in ECTV
and CPXV infections, respectively. ATIs result from the
condensation of a major protein species (160 kDa in CPXV-
BR) expressed in large amounts at late times during some
poxvirus infections (Funahashi et al., 1988). There are three
types of ATIs, distinguished by the amount and location of
associated virions. Some ATIs lack virions altogether (V
character), whereas others have particles throughout (V)
or only along the periphery (Vi) (Shida et al., 1977). Oc-
clusion of virions into the ATI is dependent on the presence
of the p4c gene product (VARV-BSH A30L) on the surface
of IMV particles, which may play a role in the retrograde
movement of IMV into ATIs. Thus p4c may affect the
overall balance of EEV, IMV, and occluded IMV particles
produced in an infected cell, and thus play a role in virus
dissemination in vivo (McKelvey et al., 2002). The p4c
homologue in the ECTV-MOS (Table 1, Region Q) and
NAV strains is fragmented, and therefore, these ECTV
isolates would not be expected to occlude IMV. ATIs may
provide a means of survival in the environment as is the
case with insect poxviruses’ dependence on an inclusion
structure called a spherule (Bergoin and Dales, 1971). Al-
ternatively, macrophages may be more efficiently infected
when virus is released in the low-pH endocytic vesicles or
lysosomal compartments following phagocytosis of ATIs
containing virus (Ulaeto et al., 1996). Although both pos-
sibilities are plausible, it is puzzling why different strains of
CPXV isolated directly from nature vary in the ability to
occlude virions in ATIs (Baxby, 1975). ORF 128 encodes
an A-type inclusion protein of 1113 aa. Currently, only
ECTV and CPXV are known to code for a complete ATI
protein (Funahashi et al., 1988); other poxviruses such as
VACV-COP and VARV-BSH contain only fragments of the
ATI. ECTV-MOS and ECTV-NAV ATI proteins are 100
and 97.5% identical to the ATI of ECTV strain MP-1, which
is 64 residues shorter (Accession No. X69325) (Osterrieder
et al., 1994). ECTV-MOS and CPXV-BR ATI genes are
approximately 85% identical at the nucleotide level, but the
proteins are less similar than expected because a series of
small deletions result in reading frameshifts in some regions
of the proteins. There are, however, regions where signifi-
cant portions of the proteins are more than 95% homolo-
gous.
Epidermal growth factor homologues
Vaccinia virus growth factor (VGF), an epidermal
growth factor (EGF) homologue, has been found in the
genomes of all sequenced leporipoxviruses and orthopox-
viruses. Studies using VACV have suggested that VGF
stimulates quiescent cells proximal to the focus of infection
to proliferate, and perhaps serves as better hosts for subse-
quent rounds of infection. VGF homologues of myxoma
virus (MYXV-LAU) and VACV-WR have been found to be
important for optimal virulence in rabbits, mice, and chick
embryos (Buller et al., 1988a,b; Opgenorth et al., 1992). In
comparison to the fully processed 77 aa VGF (VACV-COP
C11R), the EGF-like protein encoded by ORF 10.5 and the
identical homologue in ECTV-NAV are predicted to have a
processed length of 65 aa. This truncated protein, however,
may be functional because the termination codon is 4 aa
after the last of six highly conserved cysteines that are
believed to be important for structure of the protein and
results in a polypeptide that is only 5 aa shorter than the
functional MYXV EGF-like proteins (Chang et al., 1990;
Opgenorth et al., 1993). In contrast to the ECTV-MOS and
NAV strains, a gene encoding an EGF-like protein from the
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Table 2
Predicted ORFs in ECTV-MOS
Ectromelia virus strain Moscow Similarity to orthologs
Name aa Start Stop Predicted features/function VACV-COP aa % Identity VARV-BSH
001 247 2323 1580 Sec/CC-Chemokine bp C23L 244 81 Yes
002 587 4415 2652 Ankyrin repeats/unknown BSH G1R 585 91 Yes
003 320 6468 5506 Sec/TNF-bp (CrmD) BR 221 320 96 No
004 273 10,494 9673 BTB domain/unknown GRI D7L 273 88 No
005 650 12,565 10,613 Ankyrin repeats/unknown BR 011 658 93 No
006 75 12,824 12,597 C-type lectin/unknown GRI D9L 75 77 No
007 103 13,077 12,766 Sec, C-type lectin/unknown GRI C2L 96 91 No
008 202 14,019 13,411 Sec/TNFR C-terminal domain BR 014 202 92 No
009 111 14,351 14,016 Sec/vCD30 BR 015 110 90 No
010 763 16,733 14,442 Ankyrin repeats/unknown BR 016 764 91 No
010.5 83 17,589 17,840 Shortened EGF-like factor C11L 142 78 Yes
011 331 19,149 18,154 Unknown C10L 331 98 Yes
012 241 19,658 20,383 Zinc finger/apoptosis BSH D6R 242 95 Yes
013 138 20,915 20,499 IL-18bp BSH D7L 126 94 Yes
014 59 22,782 22,603 Unknown BR 026 63 87 No
015 150 24,700 24,248 Ankyrin repeats/host range C7L 150 95 Yes
016 155 25,391 24,924 Unknown C6L 151 90 Yes
017 262 27,564 26,776 Sec/complement-bp control/CD46 C3L 263 93 Yes
018 512 29,158 27,620 Kelch repeats/unknown C2L 512 97 Yes
019 117 30,199 29,846 Cytoplasmic protein/virulence N1L 117 89 Yes
020 177 30,861 30,328 -Amanitin sensitivity N2L 175 91 Yes
021 472 32,312 30,894 Ankyrin repeats/unknown M1L 472 96 Yes
022 285 33,944 33,087 Ankyrin repeats/host range K1L 284 97 Yes
023 373 35,291 34,170 Serine protease inhibitor/SPI-3 K2L 369 91 Yes
024 277 37,765 36,932 Lysophospholipase/unknown BR 045 276 96 No
025 456 39,789 38,419 Unknown F1L 226 85 Yes
026 147 40,232 39,789 Deoxyuridine triphosphatase F2L 147 97 Yes
027 482 41,708 40,260 Kelch repeats/unknown F3L 480 95 Yes
028 319 42,678 41,719 Ribonucleotide reductase-S F4L 319 99 Yes
029 74 43,927 43,703 Unknown F6L 74 93 Yes
030 82 44,190 43,942 Unknown F7L 92 80 Yes
031 65 44,528 44,331 Proline rich/not essential F8L 65 97 Yes
032 212 45,224 44,586 Membrane/unknown F9L 212 99 Yes
033 439 46,530 45,211 Serine, threonine kinase F10L 439 99 Yes
034 354 47,617 46,553 Unknown F11L 354 97 Yes
035 634 49,580 47,676 IEV actin tail formation F12L 635 96 Yes
036 372 50,731 49,613 IEV, CEV, EEV membrane F13L 372 99 Yes
037 71 50,964 50,749 Unknown F14L 73 78 Yes
038 158 51,705 51,229 Unknown F15L 158 99 Yes
039 231 52,407 51,712 Membrane/unknown F16L 231 95 Yes
040 101 52,469 52,774 Virion DNA-bound phosphoprotein F17R 101 98 Yes
041 479 54,210 52,771 Poly(A) polymerase-L E1L 479 99 Yes
042 737 56,420 54,207 Unknown E2L 737 98 Yes
043 190 57,098 56,526 dsRNA-binding/PKROAS
inhibitor
E3L 190 93 Yes
044 259 57,934 57,155 RNA polymerase, 30-kDa, VITF-1 E4L 259 100 Yes
045 331 58,015 59,010 Virosome component E5R 331 92 Yes
046 567 59,211 60,914 Unknown E6R 567 98 Yes
047 165 60,995 61,492 Myristylated/unknown E7R 166 93 No
048 273 61,620 62,441 Membrane/unknown E8R 273 98 Yes
049 1006 65,468 62,448 DNA polymerase E9L 1006 98 Yes
050 95 65,500 65,787 IMV membrane/-S-S-bond pathway E10R 95 98 Yes
051 129 66,171 65,782 IMV core E11L 129 95 Yes
052 666 68,158 66,158 Membrane/unknown O1L 666 97 Yes
053 108 68,528 68,202 Glutaredoxin/unknown O2L 108 99 Yes
054 312 69,610 68,672 IMV core, morphogenesis I1L 312 98 Yes
055 73 69,838 69,617 Membrane/unknown I2L 73 100 Yes
056 269 70,648 69,839 ssDNA-binding/phosphoprotein I3L 269 98 Yes
057 771 73,046 70,731 Ribonucleotide reductase-L I4L 771 97 Yes
058 79 73,312 73,073 IMV membrane I5L 79 97 Yes
059 382 74,479 73,331 Unknown I6L 382 99 Yes
060 423 75,743 74,472 IMV core, cysteine proteinase I7L 423 98 Yes
170 N. Chen et al. / Virology 317 (2003) 165–186
Table 2 (continued)
Ectromelia virus strain Moscow Similarity to orthologs
Name aa Start Stop Predicted features/function VACV-COP aa % Identity VARV-BSH
061 676 75,749 77,779 RNA helicase/NPH-II I8R 676 97 Yes
062 591 79,557 77,782 Putative metalloproteinase G1L 591 99 Yes
063 111 79,889 79,554 Sec/Unknown G3L 111 97 Yes
064 220 79,883 80,545 VLTF G2R 220 98 Yes
065 124 80,889 80,515 IMV membrane, -S-S-bond pathway G4L 124 99 Yes
066 434 80,892 82,196 Unknown G5R 434 97 Yes
067 63 82,204 82,395 RNA polymerase, 7-kDa subunit G5, 5R 63 100 Yes
068 165 82,397 82,894 Unknown G6R 165 96 Yes
069 371 83,974 82,859 IMV core, matrix? G7L 371 99 Yes
070 260 84,005 84,787 Late transcript factor, VLTF-1 G8R 260 100 Yes
071 340 84,807 85,829 Myristylated/unknown G9R 340 97 Yes
072 250 85,830 86,582 IMV membrane, neut ab L1R 250 99 Yes
073 87 86,614 86,877 Membrane/unknown L2R 87 97 Yes
074 346 87,907 86,867 Unknown L3L 350 94 Yes
075 251 87,932 88,687 IMV core, ssDNA binding L4R 251 99 Yes
076 128 88,697 89,083 Membrane/unknown L5R 128 100 Yes
077 153 89,040 89,501 IMV membrane, morphogenesis J1R 153 99 Yes
078 177 89,517 90,050 Thymidine kinase J2R 177 96 Yes
079 333 90,115 91,116 Poly(A) polymerase-S J3R 333 99 Yes
080 185 91,031 91,588 RNA polymerase, 22-kDa subunit J4R 185 99 Yes
081 133 92,054 91,653 Membrane/essential J5L 133 98 Yes
082 1286 92,160 96,020 RNA polymerase, 147-kDa subunit J6R 1286 99 Yes
083 171 96,532 96,017 Tyrosine/Serine phosphatase H1L 171 99 Yes
084 189 96,546 97,115 Membrane/unknown H2R 189 98 Yes
085 324 98,092 97,118 IMV membrane, surface, attach H3L 324 96 Yes
086 794 1,00,477 98,093 RNA pol-associated prot, RAP 94 H4L 795 99 Yes
087 212 1,00,663 1,01,301 Late transcript factor, VLTF-4 H5R 203 93 Yes
088 314 1,01,302 1,02,246 DNA topoisomerase type I H6R 314 99 Yes
089 146 1,02,283 1,02,723 Membrane/unknown H7R 146 96 Yes
090 843 1,02,765 1,05,296 MRNA capping enzyme-L D1R 844 98 Yes
091 146 1,05,695 1,05,255 IMV core D2L 146 99 Yes
092 237 1,05,688 1,06,401 IMV core D3R 237 97 Yes
093 218 1,06,401 1,07,057 Uracil-DNA glycosylase D4R 218 98 Yes
094 785 1,07,089 1,09,446 Nucleoside triphosphatase D5R 785 99 Yes
095 637 1,09,487 1,11,400 Early transcription factor-S D6R 637 99 Yes
096 161 1,11,427 1,11,912 RNA polymerase, 18-kDa subunit D7R 161 99 Yes
097 304 1,12,789 1,11,875 IMV membrane, attach, neut ab D8L 304 95 Yes
098 213 1,12,831 1,13,472 MutT-like/unknown D9R 213 99 Yes
099 250 1,13,469 1,14,221 MutT-like/unknown D10R 248 97 Yes
100 631 1,16,113 1,14,218 NPH-1 D11L 631 99 Yes
101 287 1,17,010 1,16,147 MRNA capping enzyme-S D12L 287 100 Yes
102 551 1,18,696 1,17,041 Virion morphogenesis, rif resist D13L 551 99 Yes
103 150 1,19,172 1,18,720 Late transcript. factor, VLTF-2 A1L 150 99 Yes
104 224 1,19,867 1,19,193 Late transcript. factor, VLTF-3 A2L 224 99 Yes
105 76 1,20,094 1,19,864 Thioredoxin/-S-S-bond pathway A2.5L 76 94 Yes
106 644 1,22,043 1,20,109 IMV core, precursor of p4b A3L 644 99 Yes
107 281 1,22,941 1,22,096 IMV matrix, morphogenesis A4L 281 94 Yes
108 164 1,22,979 1,23,473 RNA polymerase, 22 and 21-kDa A5R 164 99 Yes
109 372 1,24,588 1,23,470 Unknown A6L 372 99 Yes
110 710 1,26,744 1,24,612 Early transcription factor-L A7L 710 99 Yes
111 288 1,26,798 1,27,664 Intermed transcript, VITF-3-S A8R 288 99 Yes
112 110 1,27,993 1,27,661 IMV membrane, morphogenesis A9L 99 85 Yes
113 891 1,30,669 1,27,994 IMV core, precursor of p4a A10L 891 97 Yes
114 318 1,30,684 1,31,640 Membrane/unknown A11R 318 99 Yes
115 191 1,32,217 1,31,642 IMV core A12L 192 96 Yes
116 66 1,32,441 1,32,241 IMV membrane A13L 70 84 Yes
117 90 1,32,822 1,32,550 IMV membrane, morphogenesis A14L 90 99 Yes
117.5 53 1,33,000 1,32,842 IMV membrane, virulence A14.5L 53 100 Yes
118 94 1,33,274 1,32,990 Unknown A15L 94 98 Yes
119 377 1,34,391 1,33,258 Myristylated/unknown A16L 378 97 Yes
120 202 1,35,002 1,34,394 IMV membrane, morphogenesis A17L 203 96 Yes
121 493 1,35,017 1,36,498 DNA helicase A18R 493 98 Yes
122 77 1,36,712 1,36,479 Unknown A19L 77 97 Yes
(continued on next page)
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Table 2 (continued)
Ectromelia virus strain Moscow Similarity to orthologs
Name aa Start Stop Predicted features/function VACV-COP aa % Identity VARV-BSH
123 118 1,37,069 1,36,713 Sec/Unknown A21L 117 97 Yes
124 426 1,37,068 1,38,348 DNA pol processivity factor A20R 426 98 Yes
125 187 1,38,278 1,38,841 Holliday junction resolvase A22R 176 99 Yes
126 382 1,38,861 1,40,009 Intermed transcript, VITF-3-L A23R 382 98 Yes
127 1164 1,40,006 1,43,500 RNA polymerase, 132-kDa subunit A24R 1164 99 Yes
128 1113 1,46,834 1,43,493 A-type inclusion body BR 158 1284 58 No
129 110 1,48,775 1,48,443 IMV membrane, attach, neut ab A27L 110 95 Yes
130 146 1,49,216 1,48,776 Sec/transmembrane/unknown A28L 146 97 Yes
131 305 1,50,134 1,49,217 RNA polymerase, 35-kDa subunit A29L 305 98 Yes
132 77 1,50,330 1,50,097 IMV matrix, morphogenesis A30L 77 96 Yes
133 126 1,50,490 1,50,870 Unknown A31R 124 90 Yes
134 269 1,51,649 1,50,840 NTP-binding/DNA packaging A32L 300 99 Yes
135 185 1,51,767 1,52,324 CEV, EEV membrane surface A33R 185 90 Yes
136 168 1,52,348 1,52,854 CEV, EEV membrane surface A34R 168 95 Yes
137 176 1,52,897 1,53,427 Unknown A35R 176 96 No
137.5 160 1,53,495 1,53,977 IEV membrane A36R 221 91 Yes
138 277 1,56,092 1,55,259 Membrane, CD47/not essential A38L 277 97 Yes
139 399 1,56,107 1,57,306 Sec/Semaphorin-like A39R 403 93 Yes
140 223 1,58,609 1,57,938 Sec/immunomodulator A41L 219 91 Yes
141 134 1,58,771 1,59,175 Profilin-like A42R 133 91 Yes
142 211 1,59,215 1,59,850 Membrane/unknown A43R 194 66 Yes
143 346 1,61,192 1,60,152 Hydroxysteroid dehydrogenase A44L 346 94 Yes
144 125 1,61,240 1,61,617 Superoxide dismutase-like A45R 125 96 Yes
145 240 1,61,607 1,62,329 Inhibits NF-B activation A46R 214 98 Yes
146 244 1,63,150 1,62,416 Unknown A47L 244 96 Yes
147 227 1,63,180 1,63,863 Thymidylate kinase A48R 204 98 Yes
148 554 1,64,436 1,66,100 DNA ligase A50R 552 97 Yes
149 334 1,66,153 1,67,157 Unknown A51R 334 94 Yes
150 563 1,68,929 1,70,620 Kelch repeats/unknown A55R 564 94 Yes
151 281 1,70,670 1,71,515 CEV, EEV membrane,
hemagglutinin
A56R 315 80 Yes
152 299 1,72,283 1,73,182 Serine, Threonine kinase B1R 300 97 Yes
153 503 1,73,249 1,74,760 Schlafen-like/unknown BR 197 505 91 No
154 564 1,74,993 1,76,687 Ankyrin repeats/unknown B4R 558 94 Yes
155 317 1,76,774 1,77,727 CEV, EEV membrane, neut ab B5R 317 94 Yes
156 177 1,77,879 1,78,412 Membrane/unknown B6R 173 88 Yes
157 181 1,78,451 1,78,996 ER protein/virulence B7R 182 96 No
158 266 1,79,051 1,79,851 Sec/IFN- bp B8R 272 92 Yes
159 87 1,80,883 1,81,146 Unknown B11R 88 93 No
160 286 1,81,212 1,82,072 Serine, Threonine kinase B12R 283 94 No
161 344 1,82,164 1,83,198 Serine protease inhibitor/SPI-2 B14R 222 95 Yes
162 164 1,83,277 1,83,771 Membrane/unknown B15R 149 97 Yes
163 328 1,83,858 1,84,844 Sec/membrane protein/IL-1 bp B16R 290 83 No
164 340 1,85,921 1,84,899 Unknown B17L 340 94 Yes
165 594 1,86,011 1,87,795 Ankyrin repeats/unknown B18R 574 93 Yes
166 358 1,87,856 1,88,932 Sec/cell surface IFN- bp B19R 353 88 Yes
167 559 1,91,522 1,93,201 Kelch repeats/unknown A55R 564 25 Yes
168 370 1,93,460 1,94,572 Serine protease inhibitor/SPI-1 C12L 353 94 Yes
169 1924 1,95,563 2,01,337 Membrane/unknown BSH B22R 1897 91 Yes
170 320 2,03,304 2,04,266 Sec/TNF bp (crmD) BR 221 320 96 Yes
171 587 2,05,357 2,07,120 Ankyrin repeats/unknown BSH G1R 585 91 Yes
172 247 2,07,449 2,08,192 Sec/CC-chemokine bp C23L 244 81 Yes
Note. Name, ORF name; aa, number of amino acids; Start, first nucleotide of start codon; Stop, last nucleotide of stop codon; Similarity to orthologs:
VACV-COP, name of VACV-COP ortholog, if no vaccinia ortholog, ORFs were compared to VARV-BSH (BSH) or CPXV (strains BR and GRI); aa, number
of amino acids in ortholog; % identity, amino acid comparison; VARV-BSH, presence of ortholog. bp, binding protein; sec, secreted; BTB, (Broad-Complex,
Tramtrack and Bric a brac) also known as the POZ domain (Poxvirus and zinc finger); cys, cysteine; S, small; IMV, intracellular mature virion; IEV,
intracellular enveloped virion; EEV, extracellular enveloped virion; L, large; PKR, dsRNA-dependent protein kinase; OAS, 2-5-oligoadenylate synthetase;
VLTF, viral late transcription factor; pol, polymerase; neut ab, neutralizing antibody; attach, attachment; rif resist, rifampicin resistance; NPH I, nucleoside
triphosphate phosphohydrolase I; VITF, viral intermediate transcription factor; IEV, intracellular enveloped virion; gp, glycoprotein. Predictions: secreted
proteins by SignalP V1.1; membrane proteins by TMpred.
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putative Brazilian ECTV ICB isolate (Accession No.
AAF21105) was predicted to have a primary translation
product of similar length to VGF, and had 95 and 77% aa
identity to VGF from VACV-COP and ECTV-MOS, re-
spectively. Thus the ICB isolate may in fact be a VACV.
Schlafen-like protein
ORF 153, and its identical NAV strain homologue, is
predicted to encode a 503 aa protein. The carboxyl-terminal
300 aa is 34–43% identical to members of a family of
mouse schlafen proteins. The ECTV-MOS schlafen protein
increases the number of schlafen-like proteins in poxvirus
species to four, since similar proteins are encoded by
CMLV-M-96 (ORF 179) and CMLV-CMS (ORF 176R),
CPXV-BR (ORF 197), and MPXV-ZAI (ORF B4R). The
viral schlafen-like proteins demonstrate conservation of size
and aa composition, showing that they are closely related
and most likely originated from a common ancestor. Mouse
schlafen proteins are thought to be involved in the regula-
tion of T cell growth and development (Schwarz et al.,
1998). Therefore the poxviral homologues might interfere
with the ability of the host to generate an efficient cytotoxic
immune response against the viral infection, although there
is no experimental data to support this hypothesis. The ORF
153 equivalent in VACV COP and TIA strains are the
adjacent B2R and B3R ORFs, and in VARV-BSH a series
of three small ORFs (B2L, B3L, and B4L) and “noncoding”
sequence.
Ankyrin repeat protein family
All orthopoxviruses sequenced so far contain several
ORFs with predicted ankyrin repeat motifs. Ankyrin repeats
are thought to be important for protein–protein interaction
events between integral membrane proteins and cytoskeletal
proteins (Andrade et al., 2001). Moreover, poxvirus proteins
containing ankyrin-like motifs are thought to influence virus
host range and pathogenesis. The ECTV-MOS ankyrin re-
peat protein family contains eight distinct members: ORF
002/171, ORF 005, ORF 010, ORF015, ORF 021, ORF 022,
ORF 154, and ORF 165. BLASTP searches demonstrate
that all of these ORFs have orthologs in other orthopoxvirus
genomes with greater than 90% identity. The ancestral
ECTV ankyrin repeat protein family may have contained six
more members. Region A/AA contain a homologue of
CPXV-BR 008 that is disrupted by a frameshift and a large
deletion at the 3 end. Region C/CA shows a high degree of
relatedness to CPXV-BR 220, but has nine frameshifts and
several deletions of varying length. Region E aligns with the
last 74 aa sequence of CPXV-BR ORF 017, but contains a
predicted three-frame translation product. The protein se-
quence of Region F is related to CPXV-BR ORF 025 that
encodes the CPXV-BR CHO host range gene. Region G
shows strong homology with VACV-COP C9L, but has
undergone a large deletion at the 5 end, and three frame-
shifts. The last potential ankyrin family member is located
in the right terminal part of the genome where a three-frame
translation of ECTV-MOS Region Y aligns with the protein
sequence of CPXV-BR ORF 213.
Kelch repeat protein family
ECTV-MOS contains four genes that are predicted to
encode proteins containing kelch repeats (Interpro Acces-
sion No. IPR001798; http://www.ebi.ac.uk/interpro/): ORF
018, ORF 027, ORF 150, and ORF 167. ORF 167 was
previously designated as EV p65 or EV C13R. The first
three ORFs have homologues in VACV-COP, and all four
are present in CPXV-BR that also has two additional kelch-
like genes. The biological functions of these poxvirus pro-
teins are unknown; other proteins containing kelch motifs
are involved in a variety of activities including interaction
with microfilaments of actin (Totmenin et al., 2002). The
kelch motifs are usually found as -sheets that fold into
higher order structures such as -propellers or superbarrels
(Pfam01344; in Protein Families Database of Alignments
and Hidden Markov Models; http://www.sanger.ac.uk/
Software/Pfam/).
Lectin motif containing proteins
ORFs 006 and 007 contains motifs (Pfam-B_61649 and
Pfam-B_4314, respectively) that are present in several C-
type lectin related proteins and thought to be involved in
carbohydrate binding. Intact homologues of ORF 006 and
007 in the NAV strain are lacking due to five and seven base
insertions at nucleotide 51 and 123, respectively. Of the
other orthopoxvirus species so far examined, both of these
ORFs are conserved in CPXV-GRI, and ORF 007 is also
present in CPXV-BR. ORFs 006 and 007 may be a disrup-
tion of a larger gene as they align with the 5 and 3 regions,
respectively, of the fowlpox virus (FWPV-FCV) ORF 238
(Accession No. AF 198100). A third gene coding for a
lectin-like protein might have existed in a progenitor of
ECTV-MOS, since VACV-COP ORF A40R can be aligned
with a three frame translation of Region S (Table 1). The
A40R protein has low but significant aa homology to natural
killer cell proteins that recognize class I MHC antigens, and
a role in pathogenesis has been shown in the VACV-WR
mouse dermal, but not the intranasal, infection models
(Tscharke et al., 2002; Wilcock et al., 1999). If A40R is
indeed involved with inhibition of natural killer cell activ-
ity, it is interesting that a virus such as ECTV, which is
orders of magnitude more virulent for the mouse than
VACV, would lack such a potentially important molecule.
Viral membrane proteins
ECTV-MOS encodes 35 putative membrane proteins
(Table 2). By analogy to VACV-COP14 and 5 membrane
proteins are associated with IMV and EEV, respectively,
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with an additional protein (ORF 137.5) transiently associ-
ated with IEV. Since only 20 of the 35 putative membrane
proteins are involved in virion formation, at least some of
the remaining proteins may have alternative functions.
ECTV-MOS ORF 138 is an example of a putative mem-
brane protein with a potentially important role in the natural
virus life cycle in the animal host. ECTV-MOS ORF 138
(VACV-COP A38L homologue) contains an N-terminal
immunoglobulin superfamily domain, followed by five
membrane-spanning domains, and a short cytoplasmic tail.
ECTV-MOS ORF 138, similar to all examined orthopoxvi-
ruses to date, has low but significant homology with CD47
across its entire predicted protein sequence (29% identity
versus mouse CD47). CD47, also called integrin-associated
protein (IAP), is expressed on all cell types. CD47 is a
receptor for thrombospondin family members, is a compo-
nent of supramolecular complexes containing specific inte-
grins, and interacts with signal regulatory protein (SIRP)
(Brown and Frazier, 2001). By analogy to CD47, the or-
thopoxvirus ortholog may have the capacity to modulate a
wide range of integrin ligation events including cellular
adhesion, migration, and diapedesis, and perhaps engage an
inhibitory receptor such as SIRP, which is found on neurons
and myeloid cells (Ravetch and Lanier, 2000). Previous
studies with VACV-WR found that the A38L protein was
present in low abundance in infected cells and was not
detectable in IMV or EEV (Parkinson et al., 1995). Further-
more, A38L was not found to contribute to production of
IMV and EEV, plaque size, and virulence in the intranasal
mouse model; however, its overexpression in tissue culture
correlated with Ca2 entry into, and necrosis of, infected
cells (Parkinson et al., 1995; Sanderson et al., 1996). These
results were surprising in light of our increasing understand-
ing of CD47 biology, but may reflect the fact that VACV is
not a natural pathogen of the mouse, the intranasal route of
inoculation may not be optimal for observing A38L func-
tion, or the parameters (weight loss and signs of illness)
used to assess A38L function in the mouse lacked sufficient
sensitivity to measure an effect.
TNF receptor-protein family
The TNF receptor protein family contains the largest
number of distinct orthopoxvirus immunomodulators of any
protein family. CPXV encodes four different binding pro-
teins for TNF (CrmB, CrmC, CrmD, and CrmE) each with
different patterns of expression and/or different affinities for
TNF- and TNF- (Hu et al., 1994; Loparev et al., 1998;
Saraiva and Alcami, 2001; Smith et al., 1996). In ECTV-
MOS the CrmB homologue is missing, and the CrmC (Re-
gion V) and CrmE homologues (Region B/BA) are frag-
mented. The only ORF that appears to express a functional
TNF binding protein (vTNFbp) is ORF 003/170 (CrmD)
(Chen et al., 2000; Loparev et al., 1998). ORF 003/170 has
transcription regulation signals consistent with early and
late expression during the infection cycle; however, the
binding specificity of its vTNFbp/CrmD product remains
unclear. Surface plasmon resonance measurements indi-
cated that vTNFbp/CrmD bound to immobilized human and
rat TNF- as well as human TNF- (Loparev et al., 1998).
In the same study these findings were supported by func-
tional assays which indicated that vTNFbp/CrmD inhibited
TNF- and TNF- cytotoxicity; however, others using a
filter-based binding assay found vTNFbp/CrmD bound
mouse, human, and rat TNF-, but not human TNF-.
Full-length and presumably functional CrmD homologues
have been observed in genomes of ECTV strains MP-3,
MP-4, and Munich-SF. ORF 008 is related to the CrmB
family of poxvirus genes, has an ortholog only in CPXV
(90% identical), and is predicted to be a secreted protein.
The amino-terminal 35 aa sequence has no significant match
with the nonpoxvirus protein database, whereas there is a
42% identity with CPXV-BR Crm B over the remaining 167
residues (83%) of the protein sequence. Recently CPXV and
ECTV, but not VARV, VACV, MPXV, and CMLV, have
been shown to encode a fifth functional member of this
family, a secreted protein with homology to the receptor-
binding domain of mouse and human CD30 (Panus et al.,
2002; Saraiva et al., 2002). A CD153 binding protein
(vCD30) was shown to bind specifically and with high
affinity to the CD30 ligand, CD153, completely blocking
CD30/CD153 interaction. Because CD153 is expressed on
activated T cells, monocytes, macrophages, eosinophils, and
neutrophils, and CD30 is likewise abundant on inflamma-
tory/immune cells, production of vCD30 at the site of
ECTV infection in mouse skin may be important for dis-
ruption of the initial innate response or its amplification.
Host range proteins
Although experimental infections of a wide range of
small animal models has indicated that ECTV probably has
a very narrow host range, infecting one or a small number
of rodent species, the natural animal reservoir has yet to be
determined. The wild mouse, Mus musculus, a possible
candidate as infections of laboratory raised outbred M. mus-
culus, which were derived from feral mouse populations in
the Eastern USA and the former Czechoslovakia, showed a
pattern of disease resistance/susceptibility consistent with a
natural host for ECTV (Buller et al., 1986). This may also
explain the origins of the now well-known resistance/sus-
ceptibility disease patterns of inbred strains of laboratory
mice, which are mosaics of the genomes of European and
Asian M. musculus subspecies (Bonhomme, 1986; Wallace
and Buller, 1985; Yonekawa et al., 1982). In the broadest
context, virus host range in nature is determined by a sum-
mation of activities of viral genes that allow efficient virus
replication, spread within the animal, and transmission in
the face of inflammatory and immune host defense mecha-
nisms. Here we consider host range in a narrower sense to
mean virus functions that affect virus replication and release
from specific cell types.
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The following orthopoxvirus genes have been shown to
be involved in host range in established cell lines or primary
cultures: CHOhr (CPVX-BR 025), K1L (VACV-COP
K1L), C7L (VACV-COP C7L), p28 (RING zinc-finger,
ORF 012), SPI-1 (RPV-UTR 005), E3L (VACV-COP
E3L), and K3L (VACV-COP K3L) (Table 3). In the ECTV-
MOS genome, we identified predicted homologues for all
but the CHOhr gene (Region F) and VACV K3L (Region
M). The cell lineage tropisms governed by the CHOhr gene,
K1L, and C7L genes have been well-described (Drillien et
al., 1978, 1981; Gillard et al., 1985; Perkus et al., 1990;
Spehner et al., 1988). Although these predicted proteins are
not significantly related (except for the presence of ankyrin
repeats), C7L, K1L, and CHOhr proteins in tested porcine
or human lines, and K1L and CHOhr proteins in rabbit
RK-13 cells, are functionally interchangeable. In tissue cul-
ture, the CHOhr gene supported orthopoxvirus replication
in the broadest range of cell types tested and was shown to
delay but not block apoptosis (Ink et al., 1995), yet it is not
conserved among orthopoxviruses as the gene is fragmented
in ECTV, VARV, VACV, CMLV, and MPXV. ECTV’s
narrow host range in nature is not solely due to the lack of
a functional CHOhr gene since ECTV-MOS mutants with a
repaired CHOhr gene had an expanded capacity for repli-
cation in rabbit and hamster-derived tissue culture lines, yet
similar to ECTV-MOS (wild-type) wt, still failed to repli-
cate in the skin of the Syrian hamster (Chen et al., 1992) (M.
Buller, unpublished data). Both ORF 015 and ORF 022
have 95 and 97% identity at the aa level with VACV-COP
homologues C7L and K1L, respectively, and thus would be
expected to functionally interchange with their VACV ho-
mologues; however ORF 022 could not functionally substi-
tute for K1L and support optimal VACV replication in
rabbit-derived RK-13 and SIRC cell lines (Chen et al.,
1993). Infections of RK-13 cells with ECTV-MOS and
VACV mutants lacking an intact K1L gene resulted in
transient expression of early genes followed by rapid and
irreversible cessation of both virus and host protein synthe-
sis compatible with the onset of apoptosis. In addition,
footpad infections of the disease-susceptible ANCR or -re-
sistant C57BL/6NCR mice with a ORF 022-lacking ECTV-
MOS yielded a pathogenesis pattern indistinguishable from
wt, suggesting that the K1L host-range homologue is not
important for ECTV-MOS in vivo tissue replication, spread,
and lethality under the tested set of experimental conditions.
An intact p28 gene has been identified in a majority of
orthopoxvirus species and representatives of leporipoxvirus,
yatapoxvirus, and capripoxvirus genera, although it is dis-
rupted or deleted in the WR, COP, MVA, and TIA strains of
VACV. The prominent feature of the protein is a C-terminal
RING zinc-finger that is minimally defined by a configura-
tion of seven Cys (C) and His (H) residues necessary for
chelation of two zinc ions (C3HC4) (Freemont et al., 1991).
Although a large number of proteins with diverse functions
have a RING zinc-finger motif, the spacing between the
signature residues and the overall aa composition of pro-
teins shows considerable variation. The ECTV-MOS p28
was shown to have significant homology to the RING zinc-
finger region of proteins of unknown function from verte-
brates and invertebrates, which form the makorin protein
family (Gray et al., 2000). Studies with ECTV-MOS p28
virus in cell cultures and ANCR mice have suggested that
p28 has a very important role in the natural life cycle of
ECTV. Following footpad inoculation, the LD50 of p28
virus in ANCR mice is at least a million-fold higher, and the
infectivity burden in liver and spleen is at least a thousand-
fold lower, than wt virus (Senkevich et al., 1994). This
attenuation of ECTV-MOS pathogenicity in ANCR mice
can be explained by a failure of the virus to replicate in
macrophage lineage cells at successive steps in the spread of
virus from the skin to liver (Senkevich et al., 1995). The
diminished replication of p28 virus in macrophages from
ANCR mice may result from inefficient suppression of
apoptosis as p28 has been shown necessary to protect
ECTV-MOS-infected HeLa cells from UV-induced apopto-
sis (Brick et al., 2000).
SPI-1 is a closely related member (46% identity in
ECTV-MOS) of a serpin (serine proteinase inhibitors) su-
perfamily whose members act as suicide substrates for
serine and selected cysteine proteinases. The specificity of
the serpin is determined by the reactive-site loop (RSL),
which is designated by aa P15 to P5. The RSL interacts
directly with the target proteinase, and proteolysis occurs at
the scissile bond between residues P1 and P1, yielding a
long-lived complex. SPI-1 has been shown specifically to
interact with cathepsin G (Moon et al., 1999) and has been
Table 3
Predicted ectromelia virus host range proteins
ORF Predicted
MW kDa
Other name/motif Orthologs References
012 28.4 P28/zinc finger BSH-D6R Senkevich et al., 1994, 1995; Upton et al., 1994; Brick et al., 1998, 2000
015 18.1 Ankyrin repeats COP-C7L Perkus et al., 1990; Chen et al., 1993
022 32.7 Ankyrin repeats COP-KIL Gillard et al., 1986; Chen et al., 1993
043 21.6 P20/P25 dsRNA binding COP-E3L Chang et al., 1992; Beattie et al., 1996; Langland et al., 2002; Smith and
Alcami, 2002b
168 42.5 SPI-1/Serpin RSL COP-C12L Kotwal and Moss, 1989; Moon et al., 1999
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shown necessary for optimal host-range in vitro (A549 and
PK-15), whereas its role in vivo is less clear (Ali et al.,
1994; Kettle et al., 1995; Thompson et al., 1993). SPI-1 has
been shown to affect apoptosis in RPV-UTR-infected A549
and PK-15 cells and may do so in a caspase-independent
manner (Brooks et al., 1995; Moon et al., 1999). ECTV-
MOS SPI-1 (ORF 168) showed 95% identity with
VACV-COP homologues. The ECTV-MOS and RPV-UTR
SPI-1 homologues share an identical RSL, and therefore,
perhaps share an identical function.
E3L and K3L contribute to the host range of orthopox-
viruses by blocking endogenous antiviral pathways that are
enhanced by interferons (IFN). E3L acts as an inhibitor of
the dsRNA-dependent protein kinase (PKR) and 2-5-oli-
goadenylate synthetase (OAS) pathways by binding and
sequestering dsRNA activator molecules (Langland and Ja-
cobs, 2002). Activation of PKR by viral infection in the
absence of E3L resulted in apoptosis as did overexpression
of active PKR in the absence of infection (Lee and Esteban,
1994). K3L has partial homology to the amino-terminal
region of eIF2, inhibits autophosphorylation of PKR and
eIF2 substrate phosphorylation, and is thought to act as a
competitive inhibitor of PKR (Carroll et al., 1993; Davies et
al., 1993). A recent study by Langland and Jacobs using
VACV infections of BHK and HeLa cells found that the
importance of E3L and/or K3L for replication varied be-
tween the two cell types according to virus RNA levels,
endogenous PKR activity, and the presence of a functional
OAS pathway (Langland and Jacobs, 2002). By extrapolat-
ing these findings to ECTV, one would predict that the PKR
and OAS pathways would not be activated and exert an
antiviral effect, if the major cell type(s) important in main-
taining the virus life cycle failed to produce dsRNA that
exceeded the sequestering capacity of the ECTV E3L ho-
mologue (ORF 043). If this model was correct, there would
be no selection pressure to maintain a functional K3L gene.
Consistent with this hypothesis, the K3L homologue ap-
peared nonfunctional in the ECTV strains sequenced to
date. As compared to the VACV-COP K3L gene, the
ECTV-MOS homologue has a one-base insertion after base
93 and a two-base deletion following base 174, which re-
sulted in a three-frame translation of ECTV-MOS DNA
corresponding to Region M (Beattie et al., 1991). Interest-
ingly MPXV-ZAI also lacks an intact homologue of K3L,
and the E3L homologue has an amino terminal deletion. If
K3L and E3L homologues were solely responsible for pro-
tecting orthopoxvirus replication from the antiviral ef-
fects of IFNs, one might expect that replication of VACV
and ECTV in identical cell lines pretreated with IFNs
might be similar, or VACV replication might be more
resistant due to the presence of a functional K3L gene;
however, this is not the case (Karupiah et al., 1993a). In
mouse L929 cells the replication of a large number of
isolates of ECTV was shown to be resistant to mouse
IFN-/ and IFN-, whereas the VACV-WR was sensi-
tive (Smith and Alcami, 2002b).
ECTV attenuation of the innate response following
infection
In the early stage of infection, ECTV-MOS host response
modifiers (HRMs, Table 4) may restrict the spread of in-
flammatory cytokines in the epidermis and may block in-
tracellular responses to infection that include the following;
1) induction of apoptosis; 2) further secretion of inflamma-
tory/immune mediators; 3) synthesis or activation of intra-
cellular antiviral pathways; and 4) extracellular matrix or
cellular interactions via cell surface molecules.
ECTV-MOS HRMs target both primary and secondary
epidermal inflammatory cytokines/chemokines. vIL-1bp,
vIL-18bp, and SPI-2/CRMA inhibit the activity of primary
inflammatory cytokines (Table 4). In addition, ORF 145
(VACV-COP ORF A46R) may further inhibit IL-1 signal-
ing at a stage between receptor engagement and the Myd88
adaptor molecule (Bowie et al., 2000). In view of this
redundant targeting of the IL-1 type IR, IL-18R, and Toll-
like receptors (TLR) common MyD88/Traf 6/NF-B signal
transduction pathway, it was unexpected to find that the
ECTV-MOS homologue of VACV-COP A52R was dis-
rupted (Table 1, Region U). COP ORF A52R is a broad and
potent inhibitor of NFB activation by IL-1, IL-18R, and
multiple Toll-like receptors TLR (Harte et al., 2003). As
compared to COP A52R, ECTV strains MOS and NAV
homologues have an effective 29 and 30-bp deletion, re-
spectively, commencing 73 nucleotides downstream from
the AUG start codon. Providing a second initiation codon is
recognized in the MOS homologue, it is possible that a
106-aa protein could be made which would be homologous
with COP A52R aa 33 to 126.
Secondary epidermal cytokines/chemokines: IFN- (but
not IFN-), IFN-, TNF-, and CC chemokines are each
targeted by a specific binding protein (Table 4). By analogy
to VACV, vIFN-/bp may be found on cell surfaces of
infected and uninfected cells as well as in a soluble form,
suggesting a role for blocking IFN- autocrine and para-
crine functions (Colamonici et al., 1995). vIFN-/bp may
help break the linkage between the innate and adaptive
immune response by inhibiting the interaction of IFN-
with LC (Kaser and Tilg, 2001). An important role of
vIFN-/bp in orthopoxvirus pathogenesis was supported
by studies that found inactivation of VACV-WR vIFN-/
bp homologue resulted in virus attenuation by the intra-
nasal and intracranial routes of inoculation in mice (Cola-
monici et al., 1995; Symons et al., 1995). The in vivo role
of the vTNFbp has been studied most thoroughly in
MYXV-LAU infections of rabbits where a knockout virus
showed a marked decrease in pathogenicity (Upton et al.,
1991). TNF function may also be targeted downstream from
receptor engagement in at least two places. TNF signal
transduction and that of the IL-1 type IR, IL-18R, and TLR
may be further attenuated by an as yet to be identified virus
gene product(s) that affects NF-B activation by interfering
with IB degradation as described for CPXV (Oie and
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Pickup, 2001). Also SPI-2/CrmA was shown to block the
activity of caspase 1, 8, and 10, thereby inhibiting the
induction of apoptosis induced by a variety of different
stimuli including TNF and growth factor deprivation (Ray
et al., 1992; Ray and Pickup, 1996; Turner et al., 2000).
SPI-1 and SPI-2/CrmA was shown to attenuate apoptosis
induced via the Fas receptor by alloreactive CTL, but did
not protect virus-infected cells from virus-specific CTL,
which mainly kill targets by the granule exocytosis pathway
(Macen et al., 1996; Mullbacher et al., 1999; Wallich et al.,
2001). The viral CC chemokine binding protein (vCC-
CKbp; ORF 001/172) is the most abundant of the ECTV-
MOS-secreted proteins (Chen et al., 2000). vCC-CKbp does
not bind CXC, C, and CX3C chemokines. vCC-CKbp was
shown to block a large number of CC chemokines including
MCP-1, a major product of keratinocytes and a chemoat-
tractant for monocytes (Burns et al., 2002). Thus the CXC
chemokine, IL-8, which is a major product of activated
keratinocytes and fibroblasts and a chemoattractant for neu-
trophils, should not be affected by ECTV infection unless
there is an as yet to be discovered virus-encoded modulator
of IL-8 function. By analogy to MYXV, the vCC-CKbp
may interact with glycosaminoglycans that are found on the
exterior surface of cells and within the extracellular matrix,
thereby maintaining a high concentration of protein proxi-
mal to the focus of infection, preventing the migration of
inflammatory cells into the virus lesion (Seet et al., 2001).
Inactivation of the vCC-CKbp gene in MYXV-LAU and
rabbitpox virus strain Utrecht resulted in early leukocyte
infiltration into tissue sites of virus infection, but no effect
on virus lethality (Graham et al., 1997; Lalani et al., 1999;
Martinez-Pomares et al., 1995).
We propose the action of ECTV HRMs in the epidermis
results in a lower concentration of primary and secondary
cytokines reaching the dermis, and a failure to generate
optimal gradients of chemokines (especially CC chemo-
Table 4




Motifs/Proposed function Ortholog References
Blockers of interferon
043 21.6 Inhibits PKR and OAS COP-E3L Chang et al., 1992; Beattie et al., 1996; Langland and
Jacobs, 2002; Smith and Alcami, 2002b
083 19.7 Blocks IFN- signal transduction COP-H1L Najarro et al., 2001
158 30.5 vIFN-bp COP-B8R Upton et al., 1992; Mossman et al., 1995; Smith and Alcami,
2002b
166 41.0 vIFN-/bp COP-B19 Symons et al., 1995; Colamonici et al., 1995; Smith and
Alcami, 2002b
Cytokine/chemokine binding proteins
001/172 26.7 vCC-CKbp (T1/35-kDa) COP-C23L Smith et al., 1997; Graham et al., 1997; Smith and Alcami,
2000a
003/170 35.1 vTNFbp/CrmD BR-211 Smith et al., 1997; Loparev et al., 1998; Smith and Alcami,
2000a
009 12.2 CD153bp (vCD30) BR-014 Panus et al., 2002; Saraiva et al., 2002
013 15.8 vIL-18bp BSH-D7L Novick et al., 1999; Born et al., 2000; Calderara et al., 2001;
Symons et al., 2002a
161 38.6 SP1-2/CrmA COP-B14R Palumbo et al., 1989; Ray et al., 1992; Turner et al., 2000
163 37.5 vIL-1bp COP-B16R Spriggs et al., 1992; Alcami and Smith, 1992; Smith and
Alcami, 2000a
Complement inhibitor
017 28.6 Sec complement bp (VCP/EMICE) COP-C3L Kotwal and Moss, 1988; Isaacs et al., 1992
Specific mechanism of action unknown
008 22.4 TNFR-C terminal region BR-013
019 14.1 Cytoplasmic protein COP-N1L Kotwal et al., 1989; Bartlett et al., 2002
138 31.5 CD47-like COP-A38L Parkinson et al., 1995; Sanderson et al., 1996
139 45.4 Secreted semaphorin COP-A39R Comeau et al., 1998; Gardner et al., 2001
140 25.4 Attenuates inflammatory cell influx COP-A41L Ng et al., 2001
143 39.3 Hydroxysteroid dehydrogenase COP-A44L Moore and Smith, 1992; Sroller et al., 1998
144 13.7 Superoxide dismutase-1 COP-A45R Almazan et al., 2001
145 27.6 Attenuates IL-1 activation of
NFkappaB
COP-A46R Bowie et al., 2000
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kines) to direct first inflammatory cells and then immune T
cells to site of infection. The presence of replicating virus in
the dermis, and the additional production of HRMs, would
further restrict the activation of the endothelium to permit
the diapedesis of inflammatory cells into the primary lesion.
In addition the cytokine secretion pattern of dermal macro-
phages may be affected by a virus-encoded, secreted mem-
ber of the semaphorin family, ORF 139, which was shown
to induce monocyte aggregation through ICAM-1 and to
secrete IL-6 and IL-8 (Comeau et al., 1998). Also vIL-18bp
may hinder dermal macrophage-mediated activation of NK
cells if present. Consistent with this hypothesis, peritoneal
exudate cells from mice infected with an ECTV-MOS mu-
tant lacking vIL-18bp showed reduced NK lytic activity and
increased IFN- secretion as compared to wt (Born et al.,
2000). Similar results were obtained in the VACV-WR
intranasal mouse model (Symons et al., 2002a). vIFN-bp
may also be important in sequestering IFN-, the major
antiviral cytokine produced by activated NK cells, and also
a product of activated immune CD4 Th1 and CD8 T
cells. Endogenous IFN- production in ECTV-MOS-in-
fected C57BL/6 mice was shown critical for recovery from
infection, in part by inducing the production of inducible
nitric oxide synthase, and by analogy to VACV perhaps the
chemokine MuMig (Karupiah et al., 1993a,b, 1998; Ma-
halingam et al., 1999). The in vivo importance of poxvirus
vIFN-bps has been examined using knockout viruses in
several model systems, but the results obtained seem de-
pendent on the virus, route of infection, host, and the bind-
ing specificity of vIFN-bp (Mossman et al., 1996; Symons
et al., 2002b; Verardi et al., 2001). With an ECTV-MOS
mutant lacking vIFN-bp virulence was unaffected follow-
ing footpad infection of inbred and outbred mice (M. Buller,
unpublished data). This result may indicate that other virus
genes are able to compensate for the lack of vIFN-bp. For
example, ORF 083 may also target IFN- signal transduc-
tion (Najarro et al., 2001).
Activation of complement in the epidermis/dermis is
likely inhibited by homologues of vaccinia complement
protein (VCP). VCP inhibits both the alternative and the
classical pathways of complement activation by binding and
inhibiting C3b and C4b function and thereby reduces the
production of inflammatory mediators C3a, C4a, and C5a
(Kotwal et al., 1990; Kotwal and Moss, 1988). The ECTV-
MOS homologue of VCP is encoded by ORF 017 (Table 4)
and is also called ectromelia inhibitor of complement en-
zymes (EMICE) by analogy to the VARV homologue
SPICE (Rosengard et al., 2002). EMICE, similar to VCP
and SPICE, contains four complement control protein
[CCP; also called short consensus repeat] (SCR) modules in
common with members of the family of regulators of com-
plement activation (RCA), and contains putative heparin
binding sites that would facilitate docking on cell surfaces
and perhaps virions to inhibit complement activation (A1
Mohanna et al., 2001; Smith et al., 2000b). EMICE is highly
homologous with SPICE and VCP in CCP 2, CCP 3 and
CCP 4 differing by only 16 aa overall; however, EMICE
differs in CCP 1 from both SPICE and VCP by an identical
12 aa (including a contiguous 2 aa deletion). The signifi-
cance of these aa differences in EMICE CCP 1 on the
capacity to block activation of mouse complement awaits
elucidation.
The ECTV HRMs are proposed to attack all of the major
innate responses to infection in the skin at multiple points
and may contribute to the final character of the developing
immune response. A likely effect of the HRMs is the inhi-
bition of recruitment of inflammatory and immune cells to
the infected tissues, which extends the time for virus repli-
cation, shedding of virions into the environment, and max-
imizes the probability of virus transmission. To date there
have been no orthopoxvirus HRMs identified that block the
generation of immune T cell responses. On the contrary,
orthopoxviruses are usually associated with the generation
of long-lived immunity on recovery from infection. VACV
is used both as a live vaccine for smallpox and as a vector
to identify B and T cell epitopes on proteins from other
pathogens (Moss, 1996; Paoletti, 1996). The failure of or-
thopoxviruses to evolve efficient inhibitors of the generation
and function of immune T cells allows for a rapid contain-
ment of systemic infections. Providing the immune re-
sponse can be developed in sufficient time to limit tissue
destruction of vital internal organs, the host survives and
transmission of progeny virus continues from the primary
site of infection as in the case of ECTV infection of the
resistant C57BL/6 mouse.
Other proteins
ECTV-MOS ORF 025 is a homologue of VACV-COP
ORF F1L. ORF 025 may or may not be functional as it
contains 30 copies of an eight aa (DNGIVQDI) repeat
element very close to the N-terminus of the protein. VACV-
COP ORF F1L and CPXV-GRI ORF G1L contain only one
copy of this aa element but the ortholog in CPXV-BR (ORF
048) contains three copies of this repeat element. In other
viruses, there are repeats of a shorter sequence (DDI);
ECTV-NAV has one copy of the DDI element and 25
copies of DNGIVQDI. Interestingly, the aa sequence also
varies between the closely related strains of CPXV, CMLV,
and VARV. A number of immunomodulator proteins prob-
ably remain to be characterized as six putative secretory
proteins still lack known functions (ORFs 007, 008, 063,
123, 130, and 140).
Phylogeny
There appears to be little genetic diversity in the ECTV
species as virus isolates from world-wide outbreaks of
mousepox have been found to be serologically indistin-
guishable from the original Hampstead strain (Fenner,
1982). In addition, restriction endonuclease analysis of
genomic DNA from Hampstead and MOS strains revealed
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an almost identical pattern of fragments following digestion
with restriction endonucleases Hind III and Xho I (Mackett
and Archard, 1979). Now a more comprehensive view of
the genetic diversity of ECTV strains can be obtained by
direct comparison of the genomic sequence of the MOS
isolate with the genomic sequence of the NAV isolate. This
second strain was designated as NAV as it was isolated
from commercial, pooled mouse sera, which was the source
of a 1995 outbreak of mousepox in a laboratory mouse
colony at the Naval Medical Research Institute, Bethesda,
MD (Dick et al., 1996).
Despite the fact that the isolation of the MOS and NAV
strains was separated both temporally and geographically,
there is very little DNA sequence variation that would be
expected to have a biological consequence. The genomes of
ECTV-MOS and -NAV strains exhibit a 99.5% nucleotide
identity over their length (excluding the ITR regions). This
is similar to values obtained for strains within the VARV
species: 99.3% identity between VARV-BSH and VARV-
IND and 99.1% identity between a VARV-BSH (major
strain) and VARV-Garcia (minor strain). An interspecies
comparison of ECTV-MOS, with VACV-COP, VARV-
BSH, and CPXV yields 92, 89, and 90% nucleotide identity,
respectively, reflecting the on average, 90% nucleotide se-
quence identity for cross-species nucleotide differences
within the Orthopoxvirus genus. For comparison, capripox-
virus species, sheeppox virus, and goatpox virus exhibited
96% nucleotide identity, and strains within the species
showed greater than 99.7% nucleotide identity (Tulman et
al., 2002). The simplest explanation for the apparent lack of
diversity among strains of a species from two distantly
related genera is the fidelity of the poxvirus DNA polymer-
ase. Most differences between the MOS and NAV genomes
are located within or close to the ITRs. Compared to the
MOS strain, the NAV strain has two deletions of approxi-
mately 650 and 2220 bp starting from nucleotides 4607 and
7312, respectively. Both of these deletions are in regions of
fragmented genes in both genomes, Regions A and D in
strain MOS (Fig. 2 and Table 1). In addition to the small
number of differences between the strains that have been
mentioned above, there are two possibly more significant
changes to predicted ORFs. The phospholipase D-like gene
(VACV-COP ORF K4L) is present in strain NAV, but
disrupted in strain MOS by a four nucleotide deletion at
nucleotide 556 of the gene that results in a frameshift and
premature stop codon after 185 aa (Region N). The pre-
dicted superoxide dismutase-like protein (ORF 144) is trun-
cated in strain NAV by approximately 30 of 125 aa; it is not
clear if this affects the function of the protein because none
of the chordopoxvirus proteins have been shown to have
enzymatic activity.
Figure 3 demonstrates the predicted phylogenetic rela-
tionships between ECTV-MOS and other viruses in the
Poxviridae family. The phylogenetic inferences in Fig. 3A
and B represent a composite of the alignments of 40 differ-
ent proteins that were conserved among all of the Poxviri-
dae species with available genomic sequences. Fig. 3A
shows the predicted evolutionary relationship of represen-
tatives of nine different genera, while Fig. 3B displays the
predicted relationship between species only within the Or-
thopoxvirus genus. Figs. 3C and D show the predicted
phylogeny based upon nucleic acid sequence alignments of
the coding sequences representing either the gene for DNA
polymerase (VACV gene E9L) or the gene for nucleoside
triphosphatase (VACV gene D5R). Branch lengths of the
evolutionary trees are proportional to the number of aa or
nucleotide sequence changes between any two nodes (see
scale at the bottom of each panel). Bootstrap resampling
confidence values based upon 1000 replicates are displayed
along each branching point on the trees. The tight grouping
within the Orthopoxvirus genus shown in Fig. 3A demon-
strates the close phylogenetic relationship among these or-
thopoxvirus species in comparison to all other Poxviridae
genera. Within the orthopoxviruses, ECTV in general shows
the greatest phylogenetic distance compared with all other
orthopoxvirus species, with CPXV displaying the next most
distant set of sequences. The branching order relationships
among the orthopoxvirus species are all essentially the same
when comparing either the combined set of 40 different
protein gene alignments (Fig. 3B) or the individual nucle-
otide gene alignments (Figs. 3C and D). Minor branching
differences between VACV-COP and MPXV-ZAI in Figs.
3C and D are probably not significant. While ECTV appears
to show more evolutionary distance from other orthopoxvi-
rus species, the distances are not great enough to provide
any confidence in trying to root the tree at any particular
place.
Therefore, based on protein and nucleotide sequence
divergence no conclusions can be drawn as to the ancestral
relationships between these sequences, and no temporal
direction of evolutionary divergence can be inferred. As an
alternative, it might be possible to examine the genome
complement of apparently intact ORFs conserved between
orthopoxvirus species as a means of inferring ancestral
relationships among these genomes. When comparing con-
served gene sets between all of the orthopoxvirus species,
CPXV contains the most inclusive set of orthopoxvirus
genes (data not shown). That is, most of the genes present in
all of the other orthopoxvirus genomes are also present in
CPXV. None of the other orthopoxvirus species sequenced
to date contain such a diverse “superset” of conserved genes
similar to that contained within CPXV. While this analysis
is not definitive (it is highly dependent on the predicted gene
set for each genome, and we used a fairly conservative set
of predictions for this analysis), it does support the previ-
ously stated hypothesis that a CPX-like virus may be the
ancestor of all modern-day orthopoxvirus species (Shch-
elkunov et al., 1998).
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Materials And methods
Cells and viruses
The MOS strain of ECTV was isolated in the labora-
tory of Professor V.D. Soloviev in Moscow. In 1946 Dr.
C.H. Andrewes sent the MOS strain to Dr. Frank Fenner,
who over the years distributed the strain to a large num-
ber of investigators. A plaque-purified isolate of ECTV-
MOS (ATCC VR-1374), designated Mos-3-P2, was prop-
agated in an African green monkey kidney cell line,
BS-C-1 (ATCC CCL 26) (Chen et al., 1992). Cells were
grown in Eagle’s minimum essential medium (MEM)
containing 10% FETALCLONE II (Hyclone, Logan,
UT), 2 mM L-glutamine (GIBCO, Grand Island, NY), 100
U/ml penicillin (GIBCO), and 100 g/ml streptomycin
(GIBCO). Virus infectivity was estimated as described
previously (Chen et al., 1992).
Purification of ectromelia virus genomic DNA
Five cultures containing 2  107 BS-C-1 cells were
infected with ECTV-MOS at an m.o.i. of 1–5 PFU/cell in 5
ml of Dulbecco’s modified Eagle’s medium (DMEM, Bio-
Whittaker, Walkersville, MD) containing 2% FETAL-
CLONE II (DMEM-2). After 1 h at 37°C cultures were
supplemented with a further 10 ml of prewarmed DMEM-2
and incubated until maximum cytopathic effect. Cells were
scraped into the culture supernatant and centrifuged at 850
g for 5 min in a microcentrifuge. The cell pellet was resus-
pended in a total of 2.4 ml phosphate-buffered saline and
divided equally among four 1.5-ml microfuge tubes. The
cell suspension was frozen and thawed three times and
mixed with 600 l of 1% Triton X-100, 40 mM EDTA, and
68 mM -mercaptoethanol. A post 850 g supernatant con-
taining virions was centrifuged at 2100 g for 15 min in a
microcentrifuge. The viral DNA was extracted from virions
by SDS–proteinase K treatment followed by phenol-chlo-
roform as described before (Moss and Earl, 1998). DNA
was resuspended in ddH2O and concentration was estimated
by agarose gel electrophoresis.
Cloning and sequencing of an ectromelia virus
heterogeneous G/C-rich region
An ECTV-MOS fragment of 700 bp containing G/C-
rich region was PCR-amplified by using primers
EVGCR-5 (5-GCGCTCGAGGTTATTTATAGCA-
GATATAG-3) and EVGCR-3 (5-GCGGGATCC-
CACTAAGAGATTATTTTACC-3). After digestion
with BamHI and XhoI, this fragment was cloned into
similarly digested pGEM-7Zf() (Promega, Madison,
WI). Ten clones were selected, and their plasmid DNAs
were sequenced as described.
Estimation of the size of the direct-repeat-containing
region by gel electrophoresis
The direct-repeat-containing region was PCR-amplified
using primers LE-1.25R (5-GGACGTTATTGTTTAA-
GAAATAG-3) and LE-2.05L (5-CAAGTGTGATAC-
GATTATGAG-3). By agarose gel electrophoresis the size
of this fragment was calculated to be 962 bp using a 100-bp
DNA ladder as size markers (Life Technologies, Inc., Rock-
ville, MD). This agrees favorably with the 963-bp size
based on the assembled sequence (including nonrepeat
primer sequences). There are 10.4 repeats, and each of them
is 85 bp long.
DNA sequencing
With the exception of the terminal hairpin loops and the
right-hand end of about 33.5 kb (32 kb of which was
sequenced before) (Chen et al., 2000), the entire ECTV-
MOS genome was divided into 16 overlapping fragments of
about 11 kb (J. Esposito, personal communication). Each
fragment was amplified from genomic DNA using Expand
Long Template PCR System (Roche Diagnostics Corp.,
Indianapolis, IN) following the manufacturer’s instructions.
PCR products were purified using either ExoSAP-IT (USB
Corp., Cleveland, OH) or QIAquick PCR Purification Kit
(QIAGEN Inc., Valencia, CA), if the product was less than
10 kb. If the desired PCR fragment was contaminated with
additional products, the band of interest was gel-purified
using QIAEX II and QIAquick Gel Extraction Kits for
bands  10 and 10 kb, respectively. The left-hand end
fragment of about 18 kb was sequenced by primer walking,
the other 15 fragments were sequenced with a bank of
sequencing primers, which were designed according to the
sequence alignment of VARV-BSH and VACV-COP. Se-
quencing primers were designed to be about 450 bp apart to
ensure adequate overlap. Gap closure was achieved by
primer walking. Both strands of each fragment were se-
quenced. Sequencing reactions were carried out using CEQ
2000 Dye Terminator Cycle Sequencing with Quick Start
Kit (Beckman Coulter), and run on CEQ 2000XL DNA
Analysis System (Beckman Coulter).
DNA sequence analysis
DNA sequences were assembled from the raw sequenc-
ing data using the Staden Package. Annotation of the ge-
nome was performed using Artemis and the Viral Genome
Organizer (Upton et al., 2000) and analyzed with the EM-
BOSS Programs. The annotated genome was loaded into the
Poxvirus Orthologous Clusters database, which is available
from the Poxvirus Bioinformatics Resource Center (www.
poxvirus.org) (Ehlers et al., 2002). Pairwise comparisons of
whole genomes were performed using the programs WABA
and MUMmer.
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Fig. 3. Poxviridae phylogenetic predictions. A and B show phylogenetic predictions based upon amino acid alignments of 40 conserved protein coding
sequences derived from the complete genomic sequences of either representative Poxviridae species (A) or representative orthopoxvirus species (B). C and
D show phylogenetic predictions of aligned orthopoxvirus nucleotide sequences based on either the coding sequence of the DNA polymerase (VACV-COP
E9L equivalent) gene (C) or the coding sequence of the nucleoside triphosphatase (VACV-COP D5R equivalent) gene (D). All predictions were calculated
using the Branch-and-Bound search method with maximum parsimony as the optimality criterion. Bootstrap resampling confidence values on 1000 replicates
are displayed at each branch point. Branch lengths are proportional to distance (the number of amino acid or nucleotide changes), and the distance scale for
each prediction is given at the bottom of each panel.
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Phylogenetic prediction
To predict the evolutionary relationship between ECTV
and other Poxvirus genomes, we chose to analyze 40 dif-
ferent proteins that are conserved amongst 16 different
poxvirus species representing nine different genera that
have had their genomes completely sequenced. Each set of
40 proteins containing 16 different sequences was sepa-
rately aligned using ClustalW. Prior to phylogenetic infer-
ence, each of the 40 alignments were concatenated together
into one large contiguous alignment, and this alignment was
then imported into the program suite PAUP* version
4.0b10. Evolutionary predictions were then calculated on
the contiguous alignment of all 40 proteins from all of the
16 species; 40 proteins in a contiguous alignment from just
the Orthopoxvirus genus (seven species) and the aligned
nucleotide sequences of either the DNA polymerase gene or
nucleoside triphosphatase gene from the seven orthopoxvi-
rus species. Displayed are predictions that were made using
the Branch-and-Bound search method with maximum par-
simony as the optimality criterion.
Bootstrap resampling confidence values on 1000 repli-
cates were calculated also using Branch-and-Bound with
maximum parsimony. Evolutionary predictions, which were
calculated using maximum likelihood as the optimality cri-
terion or using Neighbor-joining clustering, produced trees
with no significant difference when compared to those ob-
tained with maximum parsimony. The Accession Nos. of
the complete genomic sequences of the viruses used in this
analysis are as follows: Amsacta moorei entomopoxvirus,
AF250284; camelpox virus strain M96, AF438165; CPXV-
BR, AF482758; ECTV-MOS, AF523264; Fowlpox virus
strain FCV, AF198100; Lumpy skin disease virus strain
Neethling, AF325528; Melanoplus sanguinipes entomopox-
virus, AF063866; Molluscum contagiosum virus, U60315;
MPXV-ZAI, AF380138; Myxoma virus strain Lausanne,
AF170726; Shope (rabbit) fibroma virus, AF170722;
Swinepox virus isolate 17077-99, AF410153; VACV-COP,
M35027; VARV-BSH, L22579; VARV minor strain Gar-
cia, Y16780; Yaba-like disease virus, AJ293568. The iden-
tities of the 40 proteins used in the analysis along with the
multiple sequence alignments are available as supplemen-
tary material at (www.poxvirus.org).
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